Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial

26 May 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobinopathies and Related Disorders
Share to Parvovirus B19 Infection Studies
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40419809
DOI: 10.1038/s41591-025-03662-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trialPMID 40419809Read ↗

Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapySemantic proximity Read ↗

Gene therapy for sickle cell disease: where we are now?Semantic proximity Read ↗

Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approachesSemantic proximity Read ↗

Gene therapy for sickle cell disease: An updateSemantic proximity Read ↗

Gene Therapy: A New Hope in Sickle Cell Disease TreatmentSemantic proximity Read ↗

Gene Therapy in a Patient with Sickle Cell DiseaseSemantic proximity Read ↗

Current state of gene therapy in sickle cell diseaseSemantic proximity Read ↗

Diverse Approaches to Gene Therapy of Sickle Cell DiseaseSemantic proximity Read ↗

Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trialsSemantic proximity Read ↗

Gene therapy with hematopoietic stem and progenitor cell for monogenic disorders: a systematic review and meta-analysisSemantic proximity Read ↗

Treating Sickle Cell Disease: Gene Therapy ApproachesSemantic proximity Read ↗

Concise Review: Lessons Learned From Clinical Trials of Gene Therapy in Monogenic Immunodeficiency DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.